Repair of cisplatin--DNA adducts by the mammalian excision nuclease.
about
HMGB1 and HMGB2 cell-specifically down-regulate the p53- and p73-dependent sequence-specific transactivation from the human Bax gene promoterDNA and the chromosome - varied targets for chemotherapyChiral discrimination in platinum anticancer drugs.Conformation, protein recognition and repair of DNA interstrand and intrastrand cross-links of antitumor trans-[PtCl2(NH3)(thiazole)].Pharmacogenomics of cisplatin sensitivity in non-small cell lung cancerMitochondrial DNA damage and its consequences for mitochondrial gene expression2.4-A crystal structure of the asymmetric platinum complex [Pt(ammine)(cyclohexylamine)]2+ bound to a dodecamer DNA duplexcis -Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospectsCommon variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.Interaction of FACT, SSRP1, and the high mobility group (HMG) domain of SSRP1 with DNA damaged by the anticancer drug cisplatinFormation and repair of interstrand cross-links in DNAAdvances in understanding the complex mechanisms of DNA interstrand cross-link repairHigh mobility group protein B1 enhances DNA repair and chromatin modification after DNA damageStructural basis for the recognition of diastereomeric 5',8-cyclo-2'-deoxypurine lesions by the human nucleotide excision repair systemDNA oligonucleotide duplexes containing intramolecular platinated cross-links: energetics, hydration, sequence, and ionic effects.The SWI/SNF chromatin-remodeling factor stimulates repair by human excision nuclease in the mononucleosome core particle.Cisplatin adducts of d(CCTCTG*G*TCTCC).d(GGAGACCAGAGG) in aqueous solution by vibrational circular dichroism spectroscopy.The XPA-binding domain of ERCC1 is required for nucleotide excision repair but not other DNA repair pathways.Targeted inhibition of Replication Protein A reveals cytotoxic activity, synergy with chemotherapeutic DNA-damaging agents, and insight into cellular function.MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer.Photo-cross-linking of XPC-Rad23B to cisplatin-damaged DNA reveals contacts with both strands of the DNA duplex and spans the DNA adduct.Towards Antitumor Active trans-Platinum Compounds.DNA interstrand crosslink repair in mammalian cells: step by step.Effects of geometric isomerism and anions on the kinetics and mechanism of the stepwise formation of long-range DNA interstrand cross-links by dinuclear platinum antitumor complexes.Targeting the OB-Folds of Replication Protein A with Small MoleculesHMGB1: the jack-of-all-trades protein is a master DNA repair mechanic.Transcription inhibition by platinum-DNA cross-links in live mammalian cells.Platinum anticancer drug damage enforces a particular rotational setting of DNA in nucleosomesNovel irreversible small molecule inhibitors of replication protein A display single-agent activity and synergize with cisplatinInteractions of DNA helicases with damaged DNA: possible biological consequences.Transcription-coupled and DNA damage-dependent ubiquitination of RNA polymerase II in vitroUsing synthetic DNA interstrand crosslinks to elucidate repair pathways and identify new therapeutic targets for cancer chemotherapy.XPB and XPD helicases in TFIIH orchestrate DNA duplex opening and damage verification to coordinate repair with transcription and cell cycle via CAK kinase.Curing metastatic cancer: lessons from testicular germ-cell tumours.Repair of cisplatin-induced DNA interstrand crosslinks by a replication-independent pathway involving transcription-coupled repair and translesion synthesisDNA polymerase η protein expression predicts treatment response and survival of metastatic gastric adenocarcinoma patients treated with oxaliplatin-based chemotherapyStructural basis of transcription: role of the trigger loop in substrate specificity and catalysis.Differential human nucleotide excision repair of paired and mispaired cisplatin-DNA adducts.Differential contributory roles of nucleotide excision and homologous recombination repair for enhancing cisplatin sensitivity in human ovarian cancer cellsRedox state-dependent interaction of HMGB1 and cisplatin-modified DNA.
P2860
Q24292041-F20F81AC-8817-4751-A988-80A3676F3FEFQ24792540-21CA9F6F-4F9F-48EB-A192-EAC6D5EC6F74Q24812493-DD0B40C3-BF34-4CF3-8F0B-397C31AD9861Q24813746-578190A6-D5DA-41C7-A791-C9D6D83CCF2DQ26863490-5AAA8240-BB42-483B-8EF7-8A19DD884C71Q27001150-C2ACF017-EC67-4AD8-B81D-2BBA5565826AQ27639789-BE25C0E1-8A1D-4B84-95AA-BDF62B822168Q27650949-1444C557-C342-4481-95B4-FEADED29FCB8Q27851470-48ECEA08-7B2C-4E55-940A-0C63E27E3B7AQ28188163-D65B563D-6DD6-4A65-BFA1-D52860E60EB0Q28296085-7E9BA6CC-AEE1-4B4D-8D7E-54CB4D8C30CCQ28299636-1CE7A4EE-6E00-49D2-8EAD-313A2971A3BEQ28513347-0B6B602F-E925-44E7-A30C-DA4F51183B8FQ30579562-8876738E-6659-46D1-B775-D419D91B53BAQ30723734-8B27A0C2-AA70-4355-97E2-52B5A270F62EQ30846029-03CCB55E-E2D6-4722-A702-B1C1C482D9E7Q30883120-53FE0EE7-F2F7-476C-B174-D4638BC489FDQ30919478-95522247-E1E0-4FE2-96EA-CE6D89F84C63Q33556289-B4EC858D-1828-4B17-9D1F-92FA4C79CD45Q33570512-3EC28034-3FA7-4C1E-941D-46568A36B8A8Q33612006-4895AB5E-5BCA-4E99-888B-F7B5B29CA490Q33649706-FB2E9306-E592-4FC7-B996-72273E8D11C2Q33669915-890CF565-344B-4D34-949C-0A6F69A9D1D0Q33675696-74252DCC-6043-4E26-BA7D-3188F424C9C0Q33781249-86623DE9-58CB-42F7-9F54-3BCEBFCB0300Q33799406-D66DD7DB-44A9-4545-8484-A5E532A1AB4EQ33882179-2BC052C0-26D8-402D-A74F-A2FD8AD7813EQ33934039-6EFC5165-6D47-42D1-8D9E-17CB88DD8437Q33994331-F7793C3A-35A7-4E7A-AEDB-FFDD068287DCQ34011942-B9F565A2-3358-4185-AF91-F1D5D3AA76C5Q34047176-072094C5-7BAE-4F7D-9FC0-E9DD129C4F1AQ34132691-B9C91423-9E3F-49AC-9810-BBE807BE1F9FQ34184951-A55C0F44-853E-4F5B-BADB-8F48AAA1FD87Q34210198-15C17541-5EF0-4675-A4A5-6C689B4A9337Q34343249-14404BEF-4F0C-4166-BEDA-8C3DD3B2190DQ34413771-B6CA3EE8-1CAC-4A88-B54A-4B278E3AC112Q34585043-8C3CF6F5-3603-4D41-951D-42AC4281BBCCQ34625375-3FCC0726-BB35-4FD3-9AE8-99F818FCE517Q34722650-0744F83D-5CF1-46C5-8A54-D7EA1BC1E8D0Q34744542-A089BD06-28ED-4937-8B36-81B9581C38FF
P2860
Repair of cisplatin--DNA adducts by the mammalian excision nuclease.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Repair of cisplatin--DNA adducts by the mammalian excision nuclease.
@en
type
label
Repair of cisplatin--DNA adducts by the mammalian excision nuclease.
@en
prefLabel
Repair of cisplatin--DNA adducts by the mammalian excision nuclease.
@en
P2093
P356
P1433
P1476
Repair of cisplatin--DNA adducts by the mammalian excision nuclease.
@en
P2093
P304
10004-10013
P356
10.1021/BI960453+
P407
P50
P577
1996-08-01T00:00:00Z